{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:28:41Z","timestamp":1790418521445,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1124\/dmd.120.000138","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T18:55:13Z","timestamp":1603306513000},"page":"84-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Characterization of the Human Intestinal Drug Transport with Ussing Chamber System Incorporating Freshly Isolated Human Jejunum"],"prefix":"10.1016","volume":"49","author":[{"given":"Kazuyoshi","family":"Michiba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko","family":"Kurimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyo","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kusuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.120.000138_bib1","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1124\/dmd.109.028829","article-title":"A comparison of pharmacokinetics between humans and monkeys","volume":"38","author":"Akabane","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.000138_bib2","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/0006-291X(91)91647-U","article-title":"Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells","volume":"175","author":"Artursson","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.120.000138_bib3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/BF02980227","article-title":"Peptide transporter substrate identification during permeability screening in drug discovery: comparison of transfected MDCK-hPepT1 cells to Caco-2 cells","volume":"30","author":"Balimane","year":"2007","journal-title":"Arch Pharm Res"},{"key":"10.1124\/dmd.120.000138_bib4","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1211\/0022357021495","article-title":"Regional transport and metabolism of ropivacaine and its CYP3A4 metabolite PPX in human intestine","volume":"55","author":"Berggren","year":"2003","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/dmd.120.000138_bib5","series-title":"Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics","author":"Brunton","year":"2011"},{"issue":"11","key":"10.1124\/dmd.120.000138_bib40","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1023\/A:1011981317451","article-title":"Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats","volume":"15","author":"Chiou W","year":"1998","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.120.000138_bib6","doi-asserted-by":"crossref","first-page":"G1151","DOI":"10.1152\/ajpgi.90649.2008","article-title":"A guide to Ussing chamber studies of mouse intestine","volume":"296","author":"Clarke","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/dmd.120.000138_bib7","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.addr.2012.09.042","article-title":"Intestinal drug transporters: an overview","volume":"65","author":"Estudante","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/dmd.120.000138_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/clpt.2008.195","article-title":"Drug-drug interactions mediated through P-glycoprotein: clinical relevance and in vitro-in vivo correlation using digoxin as a probe drug","volume":"85","author":"Fenner","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.120.000138_bib9","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s00424-003-1107-y","article-title":"The concentrative nucleoside transporter family, SLC28","volume":"447","author":"Gray","year":"2004","journal-title":"Pflugers Arch"},{"key":"10.1124\/dmd.120.000138_bib10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/bdd.751","article-title":"Pancreatoduodenectomy as a source of human small intestine for Ussing chamber investigations and comparative studies with rat tissue","volume":"32","author":"Haslam","year":"2011","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.120.000138_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-1759(87)90289-4","article-title":"Statistical considerations in the quantitation of serum immunoglobulin levels using the enzyme-linked immunosorbent assay (ELISA)","volume":"103","author":"Karpinski","year":"1987","journal-title":"J Immunol Methods"},{"key":"10.1124\/dmd.120.000138_bib12","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1016\/j.xphs.2017.04.001","article-title":"The organic anion-transporting peptide 2B1 is localized in the basolateral membrane of the human jejunum and caco-2 monolayers","volume":"106","author":"Keiser","year":"2017","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.120.000138_bib13","doi-asserted-by":"crossref","first-page":"7.17.1","DOI":"10.1002\/cpph.22","article-title":"The Ussing chamber assay to study drug metabolism and transport in the human intestine","volume":"77","author":"Kisser","year":"2017","journal-title":"Curr Protoc Pharmacol"},{"key":"10.1124\/dmd.120.000138_bib14","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1476-5381.2012.01887.x","article-title":"Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP","volume":"166","author":"Kusuhara","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1124\/dmd.120.000138_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejps.2010.03.009","article-title":"Pharmacokinetics of fexofenadine: evaluation of a microdose and assessment of absolute oral bioavailability","volume":"40","author":"Lappin","year":"2010","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.120.000138_bib16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1208\/s12248-013-9456-8","article-title":"Drug discovery and regulatory considerations for improving in silico and in vitro predictions that use Caco-2 as a surrogate for human intestinal permeability measurements","volume":"15","author":"Larregieu","year":"2013","journal-title":"AAPS J"},{"key":"10.1124\/dmd.120.000138_bib17","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/978-1-60761-688-7_18","article-title":"The use of hepatocytes to investigate drug uptake transporters","volume":"640","author":"Maeda","year":"2010","journal-title":"Methods Mol Biol"},{"key":"10.1124\/dmd.120.000138_bib18","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1023\/A:1011971303880","article-title":"Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells","volume":"15","author":"Makhey","year":"1998","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.120.000138_bib19","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1002\/jps.23609","article-title":"Establishment of novel prediction system of intestinal absorption in humans using human intestinal tissues","volume":"102","author":"Miyake","year":"2013","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.120.000138_bib20","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1021\/mp200647a","article-title":"Role of the equilibrative and concentrative nucleoside transporters in the intestinal absorption of the nucleoside drug, ribavirin, in wild-type and Ent1(-\/-) mice","volume":"9","author":"Moss","year":"2012","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.120.000138_bib21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1515\/hsz-2016-0259","article-title":"Expression, regulation and function of intestinal drug transporters: an update","volume":"398","author":"M\u00fcller","year":"2017","journal-title":"Biol Chem"},{"key":"10.1124\/dmd.120.000138_bib22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1124\/dmd.30.1.4","article-title":"Real-time quantitative polymerase chain reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA levels in Caco-2 cell lines, human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas","volume":"30","author":"Nakamura","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.000138_bib23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1124\/jpet.106.113076","article-title":"Characterization of the uptake of organic anion transporter (OAT) 1 and OAT3 substrates by human kidney slices","volume":"321","author":"Nozaki","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.120.000138_bib24","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s11095-012-0937-8","article-title":"Relevance of PepT1 in the intestinal permeability and oral absorption of cefadroxil","volume":"30","author":"Posada","year":"2013","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.120.000138_bib25","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1128\/AAC.43.10.2451","article-title":"Pharmacokinetics and absolute bioavailability of ribavirin in healthy volunteers as determined by stable-isotope methodology","volume":"43","author":"Preston","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/dmd.120.000138_bib26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ejps.2012.02.025","article-title":"Human small intestinal and colonic tissue mounted in the Ussing chamber as a tool for characterizing the intestinal absorption of drugs","volume":"46","author":"Rozehnal","year":"2012","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.120.000138_bib27","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejps.2012.10.007","article-title":"Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique","volume":"48","author":"Sj\u00f6berg","year":"2013","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.120.000138_bib28","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2174\/138920010794328922","article-title":"Predicting drug-drug interactions involving the inhibition of intestinal CYP3A4 and P-glycoprotein","volume":"11","author":"Tachibana","year":"2010","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.120.000138_bib29","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1124\/dmd.105.004192","article-title":"P-glycoprotein plays a major role in the efflux of fexofenadine in the small intestine and blood-brain barrier, but only a limited role in its biliary excretion","volume":"33","author":"Tahara","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.000138_bib30","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1002\/jps.21708","article-title":"The species differences of intestinal drug absorption and first-pass metabolism between cynomolgus monkeys and humans","volume":"98","author":"Takahashi","year":"2009","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.120.000138_bib31","doi-asserted-by":"crossref","first-page":"266","DOI":"10.18433\/J3JG7D","article-title":"Intestinal P-glycoprotein expression is multimodally regulated by intestinal ischemia-reperfusion","volume":"17","author":"Terada","year":"2014","journal-title":"J Pharm Pharm Sci"},{"key":"10.1124\/dmd.120.000138_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.dmpk.2015.01.002","article-title":"Effects of Cremophor EL on the absorption of orally administered saquinavir and fexofenadine in healthy subjects","volume":"30","author":"Tomaru","year":"2015","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.120.000138_bib33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/FPC.0b013e3282f974dc","article-title":"Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe","volume":"18","author":"Urquhart","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/dmd.120.000138_bib34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1748-1716.1951.tb00800.x","article-title":"Active transport of sodium as the source of electric current in the short-circuited isolated frog skin","volume":"23","author":"Ussing","year":"1951","journal-title":"Acta Physiol Scand"},{"key":"10.1124\/dmd.120.000138_bib35","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1021\/jm901371v","article-title":"Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination","volume":"53","author":"Varma","year":"2010","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.120.000138_bib36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev-physiol-020911-153251","article-title":"The intestinal absorption of folates","volume":"76","author":"Visentin","year":"2014","journal-title":"Annu Rev Physiol"},{"key":"10.1124\/dmd.120.000138_bib37","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1023\/A:1012103700981","article-title":"Analysis of drug permeation across Caco-2 monolayer: implication for predicting in vivo drug absorption","volume":"14","author":"Yamashita","year":"1997","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.120.000138_bib38","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1211\/jpp.61.07.0010","article-title":"Site-specific contribution of proton-coupled folate transporter\/haem carrier protein 1 in the intestinal absorption of methotrexate in rats","volume":"61","author":"Yokooji","year":"2009","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/dmd.120.000138_bib39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cca.2006.05.010","article-title":"Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males","volume":"373","author":"Zhang","year":"2006","journal-title":"Clin Chim Acta"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624076931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624076931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.120.000138","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:18:04Z","timestamp":1739956684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624076931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0090955624076931"],"URL":"https:\/\/doi.org\/10.1124\/dmd.120.000138","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of the Human Intestinal Drug Transport with Ussing Chamber System Incorporating Freshly Isolated Human Jejunum","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.120.000138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}